These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 22688327)
1. A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection. Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN Mol Biosyst; 2012 Aug; 8(8):2188-96. PubMed ID: 22688327 [TBL] [Abstract][Full Text] [Related]
2. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents. Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN Bioorg Med Chem; 2012 Aug; 20(15):4848-55. PubMed ID: 22750007 [TBL] [Abstract][Full Text] [Related]
3. Chemoinformatics in anti-cancer chemotherapy: multi-target QSAR model for the in silico discovery of anti-breast cancer agents. Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN Eur J Pharm Sci; 2012 Aug; 47(1):273-9. PubMed ID: 22538055 [TBL] [Abstract][Full Text] [Related]
4. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024 [TBL] [Abstract][Full Text] [Related]
5. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins. Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185 [TBL] [Abstract][Full Text] [Related]
6. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714 [TBL] [Abstract][Full Text] [Related]
7. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum. González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861 [TBL] [Abstract][Full Text] [Related]
8. Unified multi-target approach for the rational in silico design of anti-bladder cancer agents. Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN Anticancer Agents Med Chem; 2013 Jun; 13(5):791-800. PubMed ID: 23272967 [TBL] [Abstract][Full Text] [Related]
9. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps. Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304 [TBL] [Abstract][Full Text] [Related]
10. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action. Vilar S; Santana L; Uriarte E J Med Chem; 2006 Feb; 49(3):1118-24. PubMed ID: 16451076 [TBL] [Abstract][Full Text] [Related]
11. Linear and non-linear quantitative structure-activity relationship models on indole substitution patterns as inhibitors of HIV-1 attachment. Nirouei M; Ghasemi G; Abdolmaleki P; Tavakoli A; Shariati S Indian J Biochem Biophys; 2012 Jun; 49(3):202-10. PubMed ID: 22803336 [TBL] [Abstract][Full Text] [Related]
12. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives. Vilar S; Estrada E; Uriarte E; Santana L; Gutierrez Y J Chem Inf Model; 2005; 45(2):502-14. PubMed ID: 15807516 [TBL] [Abstract][Full Text] [Related]
13. New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. Speck-Planche A; Kleandrova VV; Cordeiro MN Eur J Pharm Sci; 2013 Mar; 48(4-5):812-8. PubMed ID: 23376211 [TBL] [Abstract][Full Text] [Related]
14. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica. Prado-Prado F; García-Mera X; Abeijón P; Alonso N; Caamaño O; Yáñez M; Gárate T; Mezo M; González-Warleta M; Muiño L; Ubeira FM; González-Díaz H Eur J Med Chem; 2011 Apr; 46(4):1074-94. PubMed ID: 21315497 [TBL] [Abstract][Full Text] [Related]
15. Fragment-based QSAR model toward the selection of versatile anti-sarcoma leads. Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN Eur J Med Chem; 2011 Dec; 46(12):5910-6. PubMed ID: 22030313 [TBL] [Abstract][Full Text] [Related]